Beyond The Sticker Price: What Arista Networks Stock Really Costs

The networking specialist looks expensive at a glance, but a patient investor is buying into future growth at a significant discount.

On the latest earnings call, Arista Networks (ANET) management described demand for its high-speed networking gear as the “best I’ve ever seen in my Arista tenure.” That demand, fueled by the buildout of AI infrastructure, is the engine behind the company’s growth. It is also the reason the stock can look expensive.

At today’s price of about $182, Arista trades at a price-to-earnings ratio of about 61.2 times its last twelve months of profit. For many, that multiple is a full stop. The valuation, however, is a function of future earnings, not past ones.

The Discount Patience Buys You

Look two years out, and the picture changes completely. On the earnings analysts expect the company to generate by 2027, that same $182 price tag represents a multiple of only about 40.0 times. That is a 35% lower multiple, a discount that materializes on its own as earnings grow into the price. A patient holder is effectively buying the second year’s earnings at that lower valuation.

The credibility of this discount rests on the underlying growth assumptions. Analysts expect revenue to grow about 22% a year to get there. That might sound ambitious, but it is actually well below the 31% growth Arista delivered over the last twelve months and the 35% it posted in the most recent quarter. In this light, the consensus forecast looks more cautious than aggressive.

And Arista Networks is far from alone: which 10 S&P 500 stocks carry the biggest hidden forward discount? Our rankings sort the entire index by how little you are really paying for each name’s growth once the out-year earnings land.

Testing The Consensus

Management’s own outlook adds another layer of credibility. On its latest call, the company gave guidance that implies it will “increase our forecast growth slightly to 27.7%” for 2026. That is comfortably above what analysts are modeling. The company also “increased our AI target now to $3.5 billion this year,” which would mean more than doubling its AI-related sales annually. Beyond being an analyst projection, the growth story is corroborated by the company’s own targets.

The growth story, however, faces the risk of hitting a supply ceiling. Management has been clear that “demand is outstripping our supply this year,” a constraint they expect to be a “1- or 2-year phenomenon.”

The Margin of Safety and The Reward

Of course, a stock priced for this kind of growth can be volatile. In past market shocks, the shares have fallen as much as 38% from peak to trough. The forward discount offers a margin of safety, not a guarantee.

It is crucial to understand that if the stock price never moves, the multiple simply compresses to 40.0 times by 2027. That only proves you did not overpay for the growth; it is not a gain in itself. The actual reward comes from price appreciation, which requires the market to keep paying a richer multiple than that floor. For instance, if the multiple settles at about 50.6 times those 2027 earnings, midway between today’s level and that floor, the stock would be worth about $229, or 27% above today’s price.

The Price You Are Really Paying

The premium you see today is not the price a patient holder is really paying. On the earnings expected two years from now, that same price represents a far more ordinary multiple. For the stock price to compound with those arriving earnings, the market must continue to value Arista’s growth from AI. This prospect is directly challenged by the company’s own disclosures on supply. The path forward for the stock will be determined by how effectively Arista resolves the constraints currently capping its growth.

And if it is exposure to technology as a whole you want, rather than this one name, a technology ETF like XLK covers that single sector.

Cheap Or Rich, Concentration Is The Real Risk

Valuation tells you what one stock might be worth – it says nothing about how much of your wealth should sit in it. When a single name dominates your portfolio, a re-rating the wrong way is not a paper loss; it is years of savings, and unwinding it later means a tax bill. There is a way to cap the downside and unwind it tax-efficiently.